Evidence map›Paper›PMID 37286600›Full record

ArticleNature2023

Heritable transcriptional defects from aberrations of nuclear architecture.

Stamatis Papathanasiou, Nikos A Mynhier, Shiwei Liu, Gregory Brunette, Ema Stokasimov, Etai Jacob, Lanting Li, Caroline Comenho, Bas van Steensel, Jason D Buenrostro and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Chromosomal Instability Drives Glioblastoma Heterogeneity and Therapeutic Opportunities.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  6. Non-cell-autonomous mechanisms of tumor initiation and relapse by chromosomal instability.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Review
  8. Article
  9. Resolving Sub-Nuclear Architecture from Compartments to Functional Domains.International journal of molecular sciences · 2026
    Review
  10. ECHOS enables spatial epigenome profiling at subcellular resolution.bioRxiv : the preprint server for biology · 2026
    Article
  11. Micronuclei: origins, assays, mechanisms, diseases and treatments.Signal transduction and targeted therapy · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Stamatis PapathanasiouDepartment of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. s.papathanasiou@imb-mainz.de.ORCID 0000-0001-6969-044X
Nikos A Mynhier *Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Shiwei Liu *Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Gregory BrunetteDepartment of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-3829-9031
Ema StokasimovDepartment of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Etai JacobSingle-Cell Sequencing Program, Dana-Farber Cancer Institute, Boston, MA, USA.
Lanting LiSingle-Cell Sequencing Program, Dana-Farber Cancer Institute, Boston, MA, USA.
Caroline ComenhoBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Bas van SteenselDivision of Gene Regulation and Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID 0000-0002-0284-0404
Jason D BuenrostroBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0001-9958-3987
Cheng-Zhong ZhangSingle-Cell Sequencing Program, Dana-Farber Cancer Institute, Boston, MA, USA. cheng-zhong_zhang@dfci.harvard.edu.ORCID 0000-0001-8825-7158
David PellmanDepartment of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. david_pellman@dfci.harvard.edu.ORCID 0000-0001-5306-8031
Harvard University · USBroad Institute · USDana-Farber Cancer Institute · USThe Netherlands Cancer Institute · NL

Funding

RESEARCH TRAINING-MEDICAL INFORMATICS 90T15LM007092 · NLM · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Nils Gehlenborg · 1992 to 2026
$32.8M
Training Program in Bioinformatics and Integrative GenomicsT32HG002295 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Peter J Park · 2001 to 2026
$15.8M
Polyploidy, Aneuploidy and Genome StabilityR01CA213404 · NCI · DANA-FARBER CANCER INST · PI PELLMAN, DAVID S · 2017 to 2024
$3.5M
Single-cell analysis of mutagenesis: from mutational mechanisms to functional consequencesK22CA216319 · NCI · DANA-FARBER CANCER INST · PI ZHANG, CHENG-ZHONG · 2017 to 2019
$596k
NCI NIH HHS K22 CA216319NCI NIH HHS R01 CA213404NHGRI NIH HHS T32 HG002295NLM NIH HHS T15 LM007092
6 · The paper itself

Abstract

Transcriptional heterogeneity due to plasticity of the epigenetic state of chromatin contributes to tumour evolution, metastasis and drug resistance

Indexed as

Chromosomal InstabilityEpigenesis, GeneticGene Expression Regulation, NeoplasticMicronuclei, Chromosome-DefectiveNeoplasmsTranscription, GeneticChromatinChromosomesClone CellsDNA DamageHumansSingle-Cell Gene Expression AnalysisChromatin

Identifiers

PMID37286600
PMCPMC10322708
OpenAlexW4379768957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.